AZTherapies, Inc.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI) (NCT03202147) | AZTherapies, Inc. | 2023-12-01 |
| A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease (NCT04428775) | AZTherapies, Inc. | 2020-09-08 |
| Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Volunteers (NCT04570644) | AZTherapies, Inc. | 2020-08-28 |
Track AZTherapies, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.